A novel nonseparation electrochemical enzyme immunoassay (NEEIA) for detecting marker proteins in undiluted blood is described. The approach is based on preferential electrochemical measurement of surface-bound enzyme-labeled reporter antibody (E-Ab), relative to an excess of this reagent in the sample solution. NEEIAs are carried out on microporous membranes coated with a thin, circular area of gold. The gold serves simultaneously as a working electrode and solid phase for immobilized capture anti-protein antibodies.
In the assay, analyte protein is incubated concurrently with the Ab-coated gold surface and excess E-Ab conjugate. Detection of bound E-Ab is achieved by introducing the substrate for the enzyme through the back side of the membrane. The product of bound E-Ab is detected immediately by oxidation or reduction at the gold electrode, and the resulting current is proportional to the concentration of protein in the sample. The feasibility of the NEEIA approach is demonstrated via the detection of prostate-specific antigen in undiluted plasma samples (n = 64), with alkaline phosphatase as the label. Use of multiple gold films deposited on the same porous membrane to perform simultaneous NEEIAs is also described. brane for 27 mm, we stopped the stirring and introduced 2 mL of the substrate solution into the chamber on the back side of the membrane.
IndexingTerms
The amperometric response after 1 mm for each gold electrode was measured simultaneously with two BAS potentiostats.
Additional experiments
were carried out to test the feasibility of performing simultaneous assays in undiluted whole blood for PSA and hOG (only as a model system). For such studies, human blood was reconstituted by mixing packed erythrocytes with plasma (both obtained from the blood bank at the University of Michigan Hospital) to achieve a whole-blood sample with a hematocrit of 40; to aliquots of this sample we then added various amounts of both PSA and hCG and fixed amounts of both the ALP-anti-PSA and ALP-anti-hOG conjugates.
These samples (2 mL total volume) were equilibrated in the diffusion cell for 27 mm with membranes bearing the two gold electrodes, after which time 2 mL of substrate solution was added to the back side of the chamber.
The Preliminary investigations in this direction were also a goal of these follow-up studies. Interestingly, when the capture anti-PSA Ab is immobilized through an intermediary reaction with immobilized Protein G or via the high-affinity avidin-biotin reaction (schemes B and C in Fig. 3 ), the PSA dose-response is essentially the same (see Fig. 4 ). The slight positive offset for the current changes obtained with membranes containing Protein G appears to be due to a somewhat increased amount of nonspecific adsorption of the ALP-anti-PSA conjugate to the surface of such membranes.
Methods of Capture Ab Immobilization
However, the amount of capture Ab deposited on the Protein G-or avidin-coated surfaces must be carefully controlled (Protein G surface: 5 g of Ab; avidin surface: 10 &g) if one is to obtain the data shown in Fig. 4 . Indeed, higher or lower amounts of bound capture anti-PSA Ab dramatically decrease the amount of ALP-anti-PSA fixed to the surface in the presence of a given amount of PSA analyte. In the case of higher amounts of capture Ab, steric crowding on the surface apparently actually decreases the immunobinding activity of these molecules, resulting in a dramatic decrease in the amount of ALP-anti-PSA bound, even at high concentrations of PSA (>30 g/L).
With optimization, however, any of the immobilization schemes depicted in 
capture product (aminophenol) efficiently at the porous gold electrode.
NEEIA Measurements of PSA in Undiluted Plasma
To assess the analytical capabilities of the NEEIA concept in physiological samples, we evaluated the PSA assay performed with capture Ab immobilized directly on the thioctic acid-treated gold-coated membranes. Because no existing commercial imznunoassay system handles whole blood, the initial assessment of NEEIA was carried out with undiluted plasma samples so that we could make a direct correlation between the NEEIA results and a conventional ETA system (i.e., Abbott IMx). For these studies, we calibrated the NEEIA system with undiluted female serum to which known amounts of PSA were added; this minimized any viscosity differences between the test samples and the calibrators.
As shown in Fig. 5 (6, 7) , and given that the reaction pH of the two assays was not the same (so that the fraction of PSA bound might be different under the two assay This concept is depicted schematically in Fig. 7 for the measurement of two analyte proteins simultaneously with a porous membrane coated with two gold electrodes (see Fig. 2 ). In this approach, substrate can diffuse from the back side only through the pores of The basic concept of using NEETA to perform simultaneous multianalyte assays has some limits. Indeed, because multiple enzyme-labeled reporter molecules must be present (see Fig. 7 ), one for each analyte to be detected, the background signal will also increase, which may yield poorer detection limits. This can be overcome by using less enzyme-labeled Ab conjugate (as done above for dual-analyte assay, where the amount of conjugate for each analyte was one-half that of the single-analyte assays). However, using less re- [ and an associated hand-held meter could be used to monitor important marker proteins rapidly in whole blood at the point of care.
